image_alt_text
7

Keith Neeves, Ph.D.

AIMBE College of Fellows Class of 2024
For innovative development of models, diagnostics, and drug delivery technologies for blood disorders.

There’s a Shortage of Blood. So Why Don’t We Make Some?

Via University of Colorado | November 15, 2024

A CU School of Medicine professor calls synthetic blood “one of the holy grails of biomedical research,” but creating an ample supply is still a long way off.

Every year, more than 14 million units (pints) of blood are transfused in the United States. Every two seconds, someone needs blood or blood products. Yet there’s a declining pool of blood donors, and blood products have a limited shelf life.

The American Red Cross declared an emergency blood shortage in July after its national blood inventory plummeted more than 25%. It resorted to offering gift cards to attract donors.

A blood-supply emergency can mean transfusion delays and rationing, endangering patients. Which raises the question… Continue reading.

...

Keith Neeves Inducted into the 2024 Class of the AIMBE College of Fellows

Via AIMBE | March 27, 2024

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Keith Neeves, Ph.D., Professor at University of Colorado Denver to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to medical and biological engineers, comprised of the top two percent of engineers in these fields. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education.”

Dr. Neeves was nominated, reviewed, and elected by peers and members of the College of Fellows “for innovative development of models, diagnostics, and drug delivery technologies for blood disorders…. Continue reading.

...